Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (111-120 of 337) with videos related to

Pageof 34
Sort By:
Clinical Pharmacokinetics|July 27, 2017
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic ModelingStein Schalkwijk, Aaron O Buaben, Jolien J M Freriksen, et al.
Journal of Clinical Pharmacology|July 21, 2023
What the Product Label Does Not Tell You About Drug-Drug Interaction Management: Time for a Re-AppraisalDavid M Burger, Marianne le Comte, Elise J Smolders, et al.
Clinical Pharmacokinetics|June 20, 2018
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge GapsRuben van der Galiën, Rob Ter Heine, Rick Greupink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2012
Lack of a clinically significant drug-drug interaction in healthy volunteers between the hepatitis C virus protease inhibitor boceprevir and the HIV integrase inhibitor raltegravirClara T M M de Kanter, Maren I Blonk, Angela P H Colbers, et al.
Pharmacogenomics|May 25, 2019
Influence of <i>CYP3A5</i> and <i>SLCO1B1</i> polymorphisms on atazanavir/r concentrations in Thai HIV-infected patientsNoppaket Singkham, Anchalee Avihingsanon, Narukjaporn Thammajaruk, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Neuropsychiatric adverse events of varenicline: a systematic review of published reportsAmir I A Ahmed, Abdullah N A Ali, Cees Kramers, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2014
Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysisClara T M M de Kanter, Jan G den Hollander, Corrien P W G M Verweij-van Wissen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2023
Outcomes of Bariatric Surgery in People With Human Immunodeficiency Virus: A Retrospective Analysis From the ATHENA CohortLeena Zino, Ferdinand Wit, Casper Rokx, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 20, 2002
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoringPatricia W H Hugen, Nienke Langebeek, David M Burger, et al.
Journal of Virus Eradication|August 3, 2016
Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai childrenTorsak Bunupuradah, Passorn Punyahotra, Tim R Cressey, et al.
Pageof 34

Showing results (111-120 of 337) with videos related to

Sort By:
Pageof 34
Clinical Pharmacokinetics|July 27, 2017
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic ModelingStein Schalkwijk, Aaron O Buaben, Jolien J M Freriksen, et al.
Journal of Clinical Pharmacology|July 21, 2023
What the Product Label Does Not Tell You About Drug-Drug Interaction Management: Time for a Re-AppraisalDavid M Burger, Marianne le Comte, Elise J Smolders, et al.
Clinical Pharmacokinetics|June 20, 2018
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge GapsRuben van der Galiën, Rob Ter Heine, Rick Greupink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2012
Lack of a clinically significant drug-drug interaction in healthy volunteers between the hepatitis C virus protease inhibitor boceprevir and the HIV integrase inhibitor raltegravirClara T M M de Kanter, Maren I Blonk, Angela P H Colbers, et al.
Pharmacogenomics|May 25, 2019
Influence of <i>CYP3A5</i> and <i>SLCO1B1</i> polymorphisms on atazanavir/r concentrations in Thai HIV-infected patientsNoppaket Singkham, Anchalee Avihingsanon, Narukjaporn Thammajaruk, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Neuropsychiatric adverse events of varenicline: a systematic review of published reportsAmir I A Ahmed, Abdullah N A Ali, Cees Kramers, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2014
Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysisClara T M M de Kanter, Jan G den Hollander, Corrien P W G M Verweij-van Wissen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2023
Outcomes of Bariatric Surgery in People With Human Immunodeficiency Virus: A Retrospective Analysis From the ATHENA CohortLeena Zino, Ferdinand Wit, Casper Rokx, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 20, 2002
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoringPatricia W H Hugen, Nienke Langebeek, David M Burger, et al.
Journal of Virus Eradication|August 3, 2016
Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai childrenTorsak Bunupuradah, Passorn Punyahotra, Tim R Cressey, et al.
Pageof 34